Prudential Financial urges shareholders to reject mini-tender offer
Get Alerts PRU Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 5.4%
EPS Growth %: -6.4%
Join SI Premium – FREE
Prudential Financial Inc. (NYSE: PRU) announced it received notice of an unsolicited mini-tender offer from Potemkin Limited to purchase up to 100,000 shares of Prudential common stock. The offer represents approximately 0.03% of Prudential's outstanding shares.
Potemkin's offer price of $60.70 per share is approximately 37.36% below Prudential's $96.90 closing price on the New York Stock Exchange on April 10, 2026. The company does not endorse the offer and recommends shareholders not tender their shares due to the price being below current market value.
Prudential stated it has no association with Potemkin, its mini-tender offer, or related documents. The offer seeks to acquire less than 5% of shares outstanding, which allows it to avoid many Securities and Exchange Commission disclosure and procedural requirements that apply to larger tender offers.
The SEC has previously cautioned investors about mini-tender offers made at below-market prices, noting that some bidders hope to catch investors off guard if they fail to compare the offer price to current market prices. Mini-tender offers do not provide investors with the same protections as larger tender offers under U.S. securities laws.
Shareholders who have not responded to the offer are advised to take no action. Those who already tendered shares may withdraw them within 14 days after delivery of their Acceptance Form by providing notice as described in the offer documents before the expiration scheduled for March 26, 2027, at 5 p.m. Eastern Time.
The company noted that Potemkin has made similar mini-tender offers for shares of other companies, according to the press release statement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ligand prices $625M convertible notes due 2031 at 0% interest
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- RedHill Biopharma closes $6M private placement with warrant upside
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Definitive Agreement, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share